Abacavir (Ziagen): Research: 2006-2012
- FDA-Led Research Team Discovers an Autoimmune Mechanism for Serious Drug-Induced Adverse Reactions (May 22, 2012)
From U.S. Food and Drug Administration
On TheBodyPRO.com
- FDA Study Finds No Link Between Ziagen and Heart Attacks (March 2011)
To read PDF, click here.
In HIV Treatment ALERTS!, from The Center for AIDS
On TheBodyPRO.com
- The Lingering Debate With Abacavir and Heart Disease (February 2010)
To read PDF, click here.
From Project Inform
- Tenofovir/Emtricitabine Performs Better Than Abacavir/Lamivudine in Subgroup of Antiretroviral-Naive, HIV-Infected Individuals (December 1, 2009)
From National Institute of Allergy and Infectious Diseases
On TheBodyPRO.com
- French Study Unexpectedly Uncovers Role of Substance Use in Heart Attacks (November 2009)
In Treatment Update, from Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- Serious Non-AIDS Health Problems (Especially Heart Problems) Appear Less Likely With Truvada Than Epzicom, But Low Bone Mineral Density Is More Likely, Switch Study Finds (October 20, 2009)
In Clinical Infectious Diseases
- Abacavir Efficacy and Cardiovascular Risk (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- DHHS Adults and Adolescents Antiretroviral Treatment Guidelines Panel's Communication Regarding Abacavir (April 4, 2008)
To read PDF, click here.
From AIDSinfo
- Major Study Finds Red Flags When Using Epzicom as First-Line Therapy in People With High Viral Load (February 28, 2008)
Combination therapy that includes ABC/3TC found less effective in subgroup of antiretroviral-naive individuals.
From U.S. National Institute of Allergy and Infectious Diseases
On TheBodyPRO.com
- Abacavir, Didanosine Associated With Higher Heart Attack Risk, D:A:D Study Finds (February 5, 2008)
An interview with Jens Lundgren, M.D.
In 15th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Study Finds Heart Trouble With Ziagen and Videx (February 4, 2008)
From Project Inform
On TheBodyPRO.com
- Position Statement by the D:A:D Steering Committee (February 4, 2008)
A discussion of the significance of a study examining the association between use of abacavir, didanosine and lamivudine and the risk of myocardial infarction.
To read PDF, click here.
From D:A:D Steering Committee
On TheBodyPRO.com
- Increased Risk of Myocardial Infarction Associated With Abacavir and ddI (February 4, 2008)
From HIV i-Base
On TheBodyPRO.com
- Abacavir Hypersensitivity Test Could Be Combined With Drug Resistance Test: Study (June 4, 2007)
From aidsmap.com
- In Uganda, Three-NRTI Regimen Including Abacavir Is Better Tolerated Than Nevirapine-Based Regimen (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
On TheBodyPRO.com
|
Advertisement
|
Email
Glossary
